Occurrence of a 3′-phosphoadenosine 5′-Phosphosulphate synthesizing system In two Ochromonas species

The presence of an enzyme capable of incorporating ³⁵SO₄^2? into 3′-phosphoadenosine 5′-phosphosulphate has been demonstrated,in Ochromonas danica and O. malhamensis. This system probably includes the enzymes ATP:sulphate adenyltransferase. E.C. 2.7.7.4 and ATP:adenylsulphate 3′-phosphotransferase, E.C. 2.7.1.25.     

CHARACTERIZATION OF THE FRACTION OBTAINED FROM THE CNS OF JIMPY MICE BY A PROCEDURE FOR MYELIN ISOLATION

Abstract— A subcellular fraction (called the 0·85-fraction) was isolated from the brains of Jimpy mice by a procedure for obtaining myelin of high purity from immature normal brains. The yield of this fraction obtained from 17-day-old Jimpy mice was only 5 per cent of that from age matched controls. In the electron microscope, the O·85-fractions obtained from 9- and 17-day-old control mice showed many multilayered whorls of myelin, whereas the corresponding fraction from the Jimpy mice was free of multilayered structures which could be recognized as myelin. Basic proteins, proteolipid protein and galactocerebrosides could not be detected in the 0·85-fraction from Jimpy mice although they were major components of the 0·85-fractions from both 9- and 17-day-old control mice. The specific activity of 2',3'-cyclic nucleotide 3'- phosphohydrolase in the Jimpy 0·85-fraction was only 15 per cent of the value for controls. These results can be explained either by the 0·85-fraction from Jimpy brain being a very abnormal 'myelin' or by its being primarily non-myelin contaminants. Little or none of the major glycoprotein found in normal myelin fractions was found in the 0·85-fraction from Jimpy brains. This finding is strong evidence indicating that the glycoprotein is closely associated with normal myelin in situ.     

THE NATURE OF SULPHATION OF URONIC ACID-CONTAINING GLYCOSAMINOGLYCANS CATALYSED BY BRAIN SULPHOTRANSFERASE

—A sulphotransferase system of rat brain catalyses the transfer of sulphate from 3′-phosphoadenosine 5′-phosphosulphate to the low-sulphated glycosaminoglycans isolated from normal adult human brain. These were shown to be precursors of higher-sulphated glycosaminoglycans by DEAE-Sephadex column chromatography and paper electrophoresis. Nitrous acid degradation and mild acid hydrolysis of enzymically-sulphated fractions further confirmed the presence of heparan sulphate in human brain. A partially purified sulphotransferase preparation was obtained from neonatal human brain using chondroitin-4-sulphate as sulphate acceptor. This sulphotransferase catalyses the transfer of sulphate to the various uronic acid containing glycosaminoglycans. Heparan sulphate was the best sulphate acceptor followed by dermatan sulphate, N-desulphoheparin, chondroitin-4-sulphate and chondroitin-6-sulphate in decreasing order. Sulphotransferase obtained from 1-day-old rat, rabbit and guinea pig brain also had the same pattern of specificity towards various sulphate acceptors. This sulphotransferase catalyses both N-sulphation and O-sulphation. Studies on the sulphotransferase obtained from both rat and human brain of various age groups indicate that the ratio of N-sulphation: O-sulphation decreases as the brain matures.     

Jimpy Mice: Quantitation of Myelin-Associated Glycoprotein and Other Proteins

Myelin-associated glycoprotein (MAG), 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) activity, myelin basic protein (BP), and proteolipid protein (PLP) were quantitated in the brains of 20-day-old Jimpy and control mice. The levels of MAG, CNPase, and BP in Jimpy brains were 5.3%, 9.7%, and 1.9% of those in control brains, respectively. Immunoblotting analysis did not reveal an increased apparent Mr for MAG in the Jimpy mouse, as has been observed in some other hypomyelinating murine mutants. PLP was reduced more than the other proteins, as it was not detected by an immunoblotting technique that was capable of detecting 0.5% of the control level.     

COMPOSITION OF CEREBRAL LIPIDS IN MURINE LEUCODYSTROPHY: THE QUAKING MUTANT

The composition of sphingolipids and phospholipids of mouse brain during myelination was determined in the Quaking mutant, which manifests a genetic disorder of myelin formation, and in littermate controls. The biochemical changes during myelination in the brains of the controls corresponded quantitatively with previous findings in a different strain of mice. The Quaking mutant exhibited concentrations of sphingolipids and phospholipids in brain which were comparable to those of controls in the early stage of myelination but the tissue content failed to increase with maturation. The greatest differences occurred in the cerebrosides which at 65 days of postnatal age were only 10 per cent of control levels. During development the pattern of cerebral levels of sphingomyelin, plasmalogen and total phospholipid in the mutants tended to resemble that of the cerebrosides. The defect in the Quaking mutant is compatible with a failure in maturation of myelin. These findings have been compared with those in the Jimpy mutant, a different genetic disorder of myelin in the mouse previously studied in a similar fashion. The Jimpy mutant is characterized by a quantitatively more pronounced deficiency of myelin lipids and a decline in cerebrosides during brain development.     

Enzymatic sulfation of a large molecular weight glycoprotein associated with pig brain membranes

Pig brain membranes catalyze the transfer of [³⁵S]sulfate from 3′-phosphoadenosine 5′-phospho[³⁵S]sulfate into two macromolecular endogenous acceptors. Several operational enzymatic properties of the sulfotransferase activity have been defined. An apparent K_m = 0.65 μm for 3′-phosphoadenosine 5′-phosphosulfate has been determined for the pig brain in vitro sulfotransferase system. Direct proof for the absolute requirement of the 3′-phosphate moiety of 3′-phosphoadenosine 5′-phosphosulfate is presented. The nucleotide end product, 3′,5′-ADP, is a potent competitive inhibitor of the pig brain sulfotransferase activity. One of the major products enzymatically labeled during incubation with 3′-phosphoadenosine 5′-phospho[³⁵S]sulfate is a membrane-bound glycoprotein of high molecular weight. The sulfated glycoprotein appears to be an integral membrane glycoprotein, requiring 1% Triton X-100 for extraction. An ³⁵S-labeled oligosaccharide, released by mild base treatment, contains O-sulfate ester groups and at least one N-acetylneuraminic acid residue. The sulfated glycoprotein has an apparent molecular weight of 198,000. Under the same in vitro conditions [³⁵S]sulfate is also incorporated into a membrane-associated ³⁵S-labeled proteoglycan having the properties of heparan sulfate. The ³⁵S-labeled proteoglycan is electrostatically bound to the pig brain membranes, and can be readily extracted with 1 m NaCl.     

2'',3''-CYCLIC NUCLEOTIDE 3''-PHOSPHOHYDROLASE IN BRAINS OF MUTANT MICE WITH DEFICIENT MYELINATION

—The brains of Jimpy and Quaking mice were compared with those of the corresponding normal controls during the course of development. The activity of 2′,3′-cyclic nucleotide 3′-phosphohydrolase (CNP) was found to be markedly reduced in the affected animals. The reduction in the Jimpy mice was greater than in the Quaking mice. The activity of CNP seems to be proportional to that of myelin in the mutant mice. A similar reduction was found in spinal cords of the mutant mice, but there was no difference in CNP activity between the sciatic nerves of the mutant mice and those of the corresponding normal controls.     

A STUDY OF LIPID COMPONENTS IN BRAIN OF THE 'JIMPY' MOUSE, A MUTANT WITH MYELIN DEFICIENCY

(1) Brain composition and developmental changes were investigated in a mutant (‘Jimpy’) mouse characterized by a severe myelin deficiency. (2) Significantly lower cholesterol, phospholipid and galactolipid values were observed, and the accumulation of these lipids during the myelination period was markedly reduced or absent. (3) The most remarkable feature of ‘Jimpy’ brain was a very small galactolipid content. In 29-day-old mutants the concentration of galactolipids was 0-18 μ moles/g wet wt., representing a 46-fold decrease when compared to values determined in normal mice. (4) There was no such striking change in the distribution of different phospholipids. However, lowered relative amounts of some phospholipids, e.g. ethanolamine plasmalogen, sphingomyelin and phosphatidylserine, were observed in ‘Jimpy’ brain. (5) Protein content was also lower in mutant brains and showed an absolute decrease after 23 days of life. (6) These data support the statement that the process of myelination is disturbed at an early stage, resulting in a deficiency of mature myelin sheaths and leading probably to the breakdown of primitive myelin structures.     

THE FATTY ACID COMPOSITION OF PHOSPHOLIPIDS AND GLYCOLIPIDS IN JIMPY MOUSE BRAIN

Abstract— Phospholipids and sphingolipids from brains of normal and Jimpy mice were isolated in a pure form by thin-layer chromatographic procedures. The fatty acid composition of the major phospholipids, i.e. ethanolamine glycerophospholipids, serine glycerophospholipids, choline glycerophospholipids and inositol glycerophospholipids, as well as sphingomyelin, cerebrosides and sulphatides was determined by gas-liquid chromatography. A specific fatty acid pattern for each of the four glycerophospholipids was found. The fatty acid composition of inositol glycerophospholipid, which has not previously been studied in mouse brain, was characterized by a high concentration of arachidonic acid. After 16 days of age, fatty acid analysis showed definite differences between the phospholipids from normal and mutant brains. A small increase of polyunsaturated fatty acids in glycerophospholipids of ethanolamine, serine and choline from the Jimpy central nervous system was found, which has been explained by the myelin deficiency. Sphingomyelin, cerebrosides and sulphatide analyses showed a wide distribution of saturated and mono-unsaturated fatty acids in both normal and mutant mice. A reduction in the amount of long-chain fatty acids was demonstrated in mutant brain sphingolipids; in sulphatides and cerebrosides, the amount of non-hydroxy fatty acids was reduced to a greater extent than in sphingomyelin. The distribution of fatty acids in sphingolipids from the myelin and microsomal fractions was also investigated in both types of mice. Cerebrosides were characterized by a high content of long-chain fatty acids in myelin as well as in microsomes. Sulphatides and sphingomyelin, on the other hand, showed a higher content of medium-chain fatty acids in microsomes than in myelin. In the mutant brain, the amount of long-chain fatty acids was reduced in both subcellular fractions. The deviation from normal in the pattern of fatty acid distribution in Jimpy brain is discussed in relation to the current concepts of glycolipid biosynthesis.     

BIOSYNTHESIS OF FREE AMINO ACIDS IN THE BRAIN OF JIMPY MICE

—The metabolism of free amino acids: γ-aminobutyric acid (GABA), glutamine, glycine and glutathione has been studied. The labelling of these free amino acids in normal and in myelin-deficient brains of Jimpy mice was followed after intraperitoneal injection of ¹⁴C-labelled glucose precursor. The quantitative distribution of these amino acids in the two kinds of mouse brain has been compared. A higher level of GABA and a faster labelling of the amino acids in Jimpy than in normal mouse brain was observed.     

INFLUENCE OF LIPIDS ON THE ACTIVITY OF CEREBROSIDE-SULPHOTRANSFERASE IN MOUSE BRAIN: A COMPARATIVE STUDY OF JIMPY AND NORMAL MOUSE BRAINS 1

Abstract— The effect of lipids other than the substrate cerebroside on the activity of cerebroside-sulphotransferase (CST) in Jimpy and normal mouse brain was investigated. The enzyme activity of an acetone-treated microsomal preparation can be stimulated in the presence of the extracted lipids either with or without addition of exogenous cerebroside as a substrate. The CST activity in the Jimpy mutant compared to that in normal animals differs from 18% in homogenate to approx 80% in solubilized or acetone-extracted microsomes. An addition of total lipid from normal mouse brain to microsomal preparations from which lipid has been removed by acetone results in a stimulation of Jimpy CST activity up to a value of 80% of normal mouse brain microsomes. Both Jimpy and normal mouse brain CST can be also stimulated by the addition of single lipid components such as cholesterol and lecithin by 50% in normal and 100% in Jimpy brain microsomes. These findings lead to the hypothesis that there is a lipid requirement for CST activity other than the substrate cerebroside.     

Studies on myelin basic protein-specific protein methylase I in various dysmyelinating mutant mice

Jimpy mice are dysmyelinating mutants characterized by producing near normal levels of myelin basic protein (MBP) in the brain but failing to incorporate these proteins into the myelin sheath. In this study, the activity of MBP-specific protein-arginine N-methyltransferase (protein methylase I) was studied in the brains of normal and jimpy mice of different ages. The enzyme activity varied little with age in normal mice but in 18 and 21 days-old homozygous jimpy mice the activity was reduced by 50% and 75% respectively from the level of their normal littermates. Interestingly, however, heterozygous jimpy mice who are phenotypically normal and quaking mice (a similar dysmyelinating mutant) showed unaltered enzyme levels.     

A Pi Form of Glutathione-S-Transferase Is a Myelin-and Oligodendrocyte-Associated Enzyme in Mouse Brain

The pi form of glutathione-S-transferase (GST), previously found to be oligodendrocyte associated, has also been found in myelin. In the brains of adult mice, immunocytochemical staining for a pi form of GST was observed in myelinated fibers, as well as oligodendrocytes. In contrast, and as previously found in rats, positive immunostaining for mu forms occurred in astrocytes and not in oligodendrocytes or myelinated fibers. Double immunofluorescence staining strengthened the conclusion that pi was in oligodendrocytes and myelin in mouse brains. The results of enzyme assays performed on brain homogenates and purified myelin indicated that GST specific activities in mouse brain myelin were almost as high (0.8-fold) as those in mouse brain homogenates. Low, but reproducible, GST activities were also observed in myelin purified from rat brains, in which pi had been demonstrated in oligodendrocytes and mu in astrocytes. The pi form was also stained by the immunoblot technique in myelin purified from mouse brain. It was concluded that pi is a myelin associated, as well as oligodendrocyte associated, enzyme in mouse brain, and possibly also in rat brain. This is the first report of localization of GSTs in mouse brain and of GST in myelin.     

Metabolism of 35S-sulphate and properties of APS-kinase and PAPS-reductase in Nitrobacter agilis

Summary The incorporation of [³⁵S]-sulphate was followed into washed-cell suspensions of Nitrobacter agilis. Thus, bound sulphate, sulphite, sulphide, cysteine, glutathione, homocysteine, methionine and taurine were detected in the ethanol-soluble fraction as well as in the residual hydrolysed fraction. The reaction between thiol groups and N-ethylmaleimide has been successfully used to stabilize the SH-compounds in cell extracts, and the derivatives thus obtained were separated by paper chromatography.A soluble enzyme system catalyzing the reduction of sulphate to sulphite has been prepared. As a result of DEAE-cellulose-11 column chromatography, the enzyme complex was cleaved into two protein bands, one containing ATP-sulphurylase and the other APS-kinase and PAPS-reductase. The last two enzymes were further purified by DEAE-sephadex and Sephadex G-150 column chromatography. At pH 7.6 the enzymes show maximal activity in the presence of ATP and an ATP-generating system (creatine phosphate and creatine phosphokinase), APS, NADP⁺, a NADP⁺-reducing system (glucose-6-phosphate and a glucose-6-phosphate dehydrogenase) and MgCl₂. Addition of small amounts of 2,3-dimercaptopropan-1-ol (BAL) to the buffers stabilized the enzymes and enabled them to be dialyzed for 16 h, without loss of activity. Anaerobic conditions are required for maximal activity.The optimum concentration of various cofactors for enzyme activity has been determined. The K _m values are as follows: ATP, 1.3×10^-3 M; APS, 1.6×10^-4 M and NADP⁺, 1.8×10^-3 M. The molecular weight of the APS-kinase and PAPS-reductase complex is about 280000. The PCMB inhibition of the two enzymes is reversed by adding GSH, L-cysteine and Cleland's reagent.Abbreviations APS adenosine 5-phosphosulphate - PAPS 3-phosphoadenosine 5-phosphosulphate - PCMB p-chloromercuribenzoate - NEM N-ethylmaleimide - PPO 2,5-diphenyloxazole - POPOP 1,4-bis-(5-phenyloxazole-2)-benzene; Cleland's reagent, dithiothreitol     

Purification and activation of brain sulfotransferase.

Galactosylceramide sulfotransferase (EC 2.8.2.11) catalyzes the biosynthesis of sulfatide from galactocerebroside and adenosine 3'-phosphate 5'-phosphosulfate (PAPS). This enzyme is developmentally controlled, reaching a maximum activity in the brains of mice corresponding to that of maximum myelination. The product, sulfatide, is an important component of myelin. This transferase from mouse brain has been purified 2600-fold using a combination of pyridoxal 5'-phosphate- and ATP-ligated columns. The purified enzyme yielded a single band following SDS-polyacrylamide gel electrophoresis with an apparent M(r) of 31,000. The entire purification procedure can be completed in 1 day. The pH optimum for the enzyme is 7.0. The Km for PAPS is 1.2 x 10(-6) M, and the Km for cerebroside is 2.6 x 10(-5) M. Cerebroside concentrations > 80 pmol/ml are inhibitory. Enzyme preparations were associated with several lipids. Vitamin K+P(i) activated purified preparations of the sulfotransferase and maintained enzyme activity during storage at -80 degrees C.     

Simultaneous inhibition of guinea pig brain 2′, 3′-cyclic nucleotide 3′-phosphohydrolase and myelin protein synthesis by 2′-adenosine monophosphate

Although the function of 2′,3′-cyclic nucleotide 3′-phosphohydrolase (CNPase) in myelin is unknown, the enzyme has been implicated in the metabolism of myelin proteins. Using 2′-AMP to inhibit CNPase, we examined the effect of reduced enzyme activity on the $\text{in vitro}$ incorporation of ¹⁴C-leucine into brain proteins. The results of this study revealed that (1) guinea pig brain homogenates incorporate leucine into protein from a sucrose medium in a linear fashion, (2) all brain fractions (cytosol, myelin, and microsomes) are labelled within 1 hr, (3) 2′-AMP inhibition of CNPase by 50% results in a similar inhibition of brain protein synthesis, and (4) the reduced protein synthesis is accompanied by a shift in label from myelin proteins to those found in the microsomes. These results are consistent with a role for CNPase in myelin protein synthesis.     

Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease

Monogalactosyl diglyceride has previously been demonstrated to be intimately associated with brain white matter, especially myelin. Enzymes responsible for its biosynthesis and degradation have been reported to be present in rat and mouse brain. In the present study, the β-galactosidase responsible for the degradation of this brain specific compound was demonstrated to be extremely deficient in brain, liver and skin fibroblasts from patients who died of Krabbe's disease. This deficiency is the third enzymatic block demonstrated in this disorder. The β-galactosidase activity toward galactocerebroside and psychosine is also extremely deficient. This finding provides new information about the substrate recognition pattern of this enzyme and about the possible etiology of globoid cell leukodystrophy.     

Enzymatic sulphation of some galactose- containing sphingolipids in developing rat brain

Abstract— Cerebroside sulphotransferase has been found to catalyze the transfer of sulphate from 3′-phosphoadenosine-5′-phosphosulfate (PAPS) to both the α-hydroxy fatty acid galactosylceramides and the nonhydroxy fatty acid galactosylceramides. The sulphotransferase has a higher affinity for the α-hydroxy fatty acid galactosylceramides than for the nonhydroxy fatty acid galactosylceramides and will also use lactosylceramide as an acceptor for the transfer of sulphate from PAPS. A second sulphotransferase, PAPS: psychosine sulphotransferase, is also present in the developing rat brain and will catalyse the transfer of sulphate from PAPS to galactosylsphingosine and lactosylsphingosine. The sulphate moiety was determined to be on the galactose and most likely on the 3′ position giving a proposed structure of: 3-O-SO₄-galactosylsphingosine. The possible role of this later pathway in the synthesis of sulphogaiactosylceramide remains to be elucidated.     

Effect of magnesium deficiency on the metabolism of glycosamino-glycans in rats

Magnesium deficiency in rats has significant effect on the concentration of different glycosaminoglycans in the tissues, the nature of the change being different in different tissues. Total glycosaminoglycans, chondroitin-4-sulphate + chondroitin-6-sulphate and dermatan sulphate increased in the aorta while hyaluronic acid, heparan sulphate and heparin decreased. In the liver, total glycosaminoglycans, hyaluronic acid, chondroitin-4-sulphate + 6-sulphate and heparin decreased while total glycosamino-glycans and all the glycosaminoglycan fractions increased in the heart. In the kidney, total glycosaminoglycans showed no significant alteration, hyaluronic acid and heparin decreased while chondroitin-4-sulphate + 6-sulphate increased. Activity of biosynthetic enzymesviz. glucosamine-o-phosphate isomerase and UDPG-dehydrogenase showed decrease in the liver. The concentration of 3’-phosphoadenosine 5’-phosphosulphate, activity of sulphate activating system and sulphotransferase were also similarly altered in the liver in magnesium deficiency.     

COMPOSITION OF CEREBRAL LIPIDS IN MURINE SUDANOPHILIC LEUCODYSTROPHY: THE JIMPY MUTANT

Abstract— The composition of sphingolipids and phospholipids of mouse brain during myelination was determined in normal animals and in mice with a genetically-determined disorder of myelin formation. Myelination was normally characterized by a two-fold increase in total phospholipids of brain, a four-fold increase in total sphingolipids, and a six-fold increase in cerebrosides. The Jimpy mutant, with defective formation of myelin in the central nervous system, demonstrated a marked deficiency of cerebrosides and a significantly lower content of total sphingolipids, without alteration of the composition of phospholipids. The increasing content of cerebrosides in the brains of the leucodystrophic mutant at the time in development when myelination is most active and the subsequent relative deficit suggest that the failure of myelin formation is not the result of a defect in biosynthesis of cerebrosides.